Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Hypersensitivity Reaction

  Free Subscription

Articles published in J Dermatol

Retrieve available abstracts of 133 articles:
HTML format

Single Articles

    June 2022
  1. KATOH N, Saeki H, Kataoka Y, Etoh T, et al
    Evaluation of standard treatments for managing adult Japanese patients with inadequately controlled moderate-to-severe atopic dermatitis: Two-year data from the ADDRESS-J disease registry.
    J Dermatol. 2022 Jun 17. doi: 10.1111/1346-8138.16485.
    PubMed     Abstract available

  2. YANAGIDA N, Takahagi S, Aoyama Y, Tanaka A, et al
    Anhidrosis accompanied by cholinergic urticaria-like rash and dermal pain in a patient with Sjogren's syndrome.
    J Dermatol. 2022;49:666-670.
    PubMed     Abstract available

    May 2022
  3. SALAVA A, Salo V, Remitz A
    Keratosis pilaris and filaggrin loss-of-function mutations in patients with atopic dermatitis - Results of a Finnish cross-sectional study.
    J Dermatol. 2022 May 26. doi: 10.1111/1346-8138.16477.
    PubMed     Abstract available

    Case of allergic contact dermatitis due to nickel contained in stainless steel skull pins.
    J Dermatol. 2022 May 3. doi: 10.1111/1346-8138.16421.

  5. TAKAMIYAGI S, Iriki H, Asahina Y, Furuichi Y, et al
    Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    J Dermatol. 2022 May 2. doi: 10.1111/1346-8138.16415.
    PubMed     Abstract available

  6. HASHIZUME H, Ajima S, Ishikawa Y
    Immunoglobulin A vasculitis post-severe acute respiratory syndrome coronavirus 2 vaccination and review of reported cases.
    J Dermatol. 2022;49:560-563.
    PubMed     Abstract available

    April 2022
  7. KIMURA H, Umemori Y, Yuki D
    Anaphylactic shock-like symptoms due to niacin overdose: A case report.
    J Dermatol. 2022 Apr 27. doi: 10.1111/1346-8138.16410.

  8. YU R, Chen S, Pan Y, Ma C, et al
    Combined use of cyclosporine in the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2022 Apr 19. doi: 10.1111/1346-8138.16369.
    PubMed     Abstract available

  9. KURIHARA K, Fujiyama T, Tokura Y, Honda T, et al
    Possible involvement of interleukin-22-producing CD103(+) CD8(+) T cells in the epidermal hyperplasia of atopic dermatitis.
    J Dermatol. 2022 Apr 1. doi: 10.1111/1346-8138.16382.

  10. GAMBICHLER T, Abu Rached N, Scholl L, Behle B, et al
    Reproducible leukocytoclastic vasculitis following severe acute respiratory syndrome coronavirus 2 vaccination.
    J Dermatol. 2022;49:145-146.

    March 2022
  11. KAN T, Tanaka A, Kanamoto M, Morioke S, et al
    Longitudinal prevalence of atopic dermatitis among freshmen at Hiroshima University between 2002 and 2019.
    J Dermatol. 2022 Mar 22. doi: 10.1111/1346-8138.16366.
    PubMed     Abstract available

  12. MAENO M, Tamagawa-Mineoka R, Arakawa Y, Masuda K, et al
    Facial discoid lupus erythematosus during dupilumab treatment for atopic dermatitis.
    J Dermatol. 2022 Mar 18. doi: 10.1111/1346-8138.16356.

  13. HE W, Hu X, Hua H, Li K, et al
    Allergic contact stomatitis due to desensitizing toothpastes.
    J Dermatol. 2022 Mar 8. doi: 10.1111/1346-8138.16338.
    PubMed     Abstract available

  14. MATSUSHIMA Y, Mizutani K, Iida S, Ichishi M, et al
    Severe skin inflammation leads to salivary gland atrophy and dysfunction.
    J Dermatol. 2022 Mar 7. doi: 10.1111/1346-8138.16334.
    PubMed     Abstract available

  15. UCHIYAMA A, Fujiwara C, Inoue Y, Motegi SI, et al
    Real-world effectiveness and safety of baricitinib in Japanese patients with atopic dermatitis: A single-center retrospective study.
    J Dermatol. 2022 Mar 6. doi: 10.1111/1346-8138.16350.

  16. LEE E, Lee S, Tashiro Y, Ogihara M, et al
    Sequential screening of biomarkers in a case of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms occurring with virus reactivation and autoimmune disease.
    J Dermatol. 2022 Mar 3. doi: 10.1111/1346-8138.16341.

  17. KOREKAWA A, Nakajima K, Fukushi K, Nakano H, et al
    Three cases of drug-induced hypersensitivity syndrome associated with mRNA-based coronavirus disease 2019 vaccines.
    J Dermatol. 2022 Mar 3. doi: 10.1111/1346-8138.16347.
    PubMed     Abstract available

  18. KONO T, Miyachi Y, Kawashima M
    Reply to Comment on "Clinical significance of the water retention and barrier function-improving capabilities of ceramide-containing formulations: A qualitative review".
    J Dermatol. 2022;49:e124.

    February 2022
  19. OKUNE M, Okiyama N, Fukuzono M, Sasaki K, et al
    Development of systemic lupus erythematosus after dupilumab treatment in a case of atopic dermatitis.
    J Dermatol. 2022 Feb 27. doi: 10.1111/1346-8138.16322.
    PubMed     Abstract available

  20. NAKAZAWA S, Phadungsakswasdi P, Kageyama H, Fukuchi K, et al
    Decreased serum level of suprabasin in patients with nickel allergy.
    J Dermatol. 2022 Feb 17. doi: 10.1111/1346-8138.16315.

  21. NISHIOKA K, Koizumi A, Takita Y
    Seven cases of contact dermatitis due to stearyl alcohol contained in topical medications.
    J Dermatol. 2022 Feb 16. doi: 10.1111/1346-8138.16325.
    PubMed     Abstract available

  22. HARADA K, Hagiwara T
    Gardner-Diamond syndrome complicated with chronic urticaria successfully treated with antihistamine.
    J Dermatol. 2022;49:e75-e76.

    January 2022
  23. HATTORI N, Koike Y, Murota H
    Treatment with an interleukin-17 inhibitor resulted in complete remission of psoriasis and flare-up of atopic dermatitis.
    J Dermatol. 2022 Jan 17. doi: 10.1111/1346-8138.16308.

  24. JEDLOWSKI PM, Jedlowski MF
    Coronavirus disease 2019-associated immunoglobulin A vasculitis/Henoch-Schonlein purpura: A case report and review.
    J Dermatol. 2022;49:190-196.
    PubMed     Abstract available

  25. JIN WJ, Ahn SW, Jang SH, Hong SM, et al
    Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination.
    J Dermatol. 2022;49:e34-e35.

  26. OHATA M, Oda Y, Washio K, Fukunaga A, et al
    Efficacy of additional treatment for chronic spontaneous urticaria refractory to treatment - A single-center retrospective real-world study.
    J Dermatol. 2022;49:e7-e8.

    December 2021
  27. BABA A, Kanekura T, Tsubouchi H
    Lichenoid drug eruption after coronavirus disease 2019 vaccination.
    J Dermatol. 2021 Dec 27. doi: 10.1111/1346-8138.16294.

  28. INAZAWA-TERADA M, Namiki T, Omigawa C, Fujimoto T, et al
    An epidemiological survey of anhidrotic/hypohidrotic ectodermal dysplasia in Japan: High prevalence of allergic diseases.
    J Dermatol. 2021 Dec 13. doi: 10.1111/1346-8138.16278.
    PubMed     Abstract available

  29. HIRANO Y, Kosumi H, Miyazawa H, Yanagi T, et al
    Toxic epidermal necrolysis induced by tirabrutinib.
    J Dermatol. 2021 Dec 5. doi: 10.1111/1346-8138.16274.

  30. KONO T, Miyachi Y, Kawashima M
    Clinical significance of the water retention and barrier function-improving capabilities of ceramide-containing formulations: A qualitative review.
    J Dermatol. 2021;48:1807-1816.
    PubMed     Abstract available

  31. IWATA H, Kamiya K, Kado S, Nakaya T, et al
    Case of immunoglobulin A vasculitis following coronavirus disease 2019 vaccination.
    J Dermatol. 2021;48:e598-e599.

    November 2021
  32. MIYAGAWA A, Adachi T, Kobayashi Y, Takamiyagi S, et al
    Plasmapheresis as a promising treatment option in apalutamide-associated toxic epidermal necrolysis.
    J Dermatol. 2021 Nov 26. doi: 10.1111/1346-8138.16248.

  33. MATSUMOTO Y, Imamura S, Fukumoto A, Lee K, et al
    Case of oral mite anaphylaxis: Contamination of wheat flour by mites determined by enzyme-linked immunosorbent assay.
    J Dermatol. 2021 Nov 18. doi: 10.1111/1346-8138.16227.

  34. NAKAMURA R, Tanaka A, Kinoshita H, Ishii K, et al
    Minocycline-induced anaphylaxis mediated by antigen-specific immunoglobulin E.
    J Dermatol. 2021 Nov 9. doi: 10.1111/1346-8138.16228.

  35. HASHIZUME H, Ishikawa Y, Ajima S
    Is steroid pulse therapy a suitable treatment for drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms? A systematic review of case reports in patients treated with corticosteroids in Japan.
    J Dermatol. 2021 Nov 9. doi: 10.1111/1346-8138.16230.
    PubMed     Abstract available

  36. TOUBI E, Vadasz Z
    Predictive features associated with chronic spontaneous urticaria recurrence.
    J Dermatol. 2021;48:1786-1788.
    PubMed     Abstract available

  37. WU RW, Lin TK
    Oxford-AstraZeneca COVID-19 vaccine-induced acute localized exanthematous pustulosis.
    J Dermatol. 2021;48:e562-e563.

  38. MAURELLI M, Bellinato F, Girolomoni G
    Adrenergic urticaria successfully treated with omalizumab.
    J Dermatol. 2021;48:e541-e542.

  39. CHEN TL, Yip HT, Wang JH, Chang CH, et al
    Risk of chronic spontaneous urticaria in reproductive-aged women with abnormal uterine bleeding: A population-based cohort study.
    J Dermatol. 2021;48:1754-1762.
    PubMed     Abstract available

  40. OKU A, Nakai K, Ikenaga T, Sato K, et al
    Case of afatinib-induced severe purpuric drug eruption with gastrointestinal bleeding.
    J Dermatol. 2021;48:e534-e535.

    October 2021
  41. MIURA S, Moriyama T, Yoshimura J, Umehara K, et al
    Anaphylaxis to lipid transfer protein from butterbur scape.
    J Dermatol. 2021 Oct 29. doi: 10.1111/1346-8138.16213.

  42. SATO A, Takemori C, Fukumoto T, Aoyama N, et al
    Cutaneous leukocytoclastic vasculitis induced by thiamazole.
    J Dermatol. 2021 Oct 22. doi: 10.1111/1346-8138.16205.

  43. GOTO T, Kogure A, Kuwano Y
    Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with skin eruptions mimicking acute generalized exanthematous pustulosis.
    J Dermatol. 2021 Oct 8. doi: 10.1111/1346-8138.16190.

  44. KAGE P, Simon JC, Treudler R
    Case of atopic eczema treated with dupilumab throughout conception, pregnancy, and lactation.
    J Dermatol. 2021;48:E484-E485.

  45. KURIYAMA Y, Shimizu A, Oka H, Sato M, et al
    Erythema nodosum-like eruption in coronavirus disease 2019: A case report and literature review of Asian countries.
    J Dermatol. 2021;48:1588-1592.
    PubMed     Abstract available

  46. LIU KL, Tsai TL, Tsai WC, Tsai SF, et al
    Prenatal heavy metal exposure, total immunoglobulin E, trajectory, and atopic diseases: A 15-year follow-up study of a Taiwanese birth cohort.
    J Dermatol. 2021;48:1542-1549.
    PubMed     Abstract available

    September 2021
  47. HUANG HL, Xu HM, Liu YD, Shou DW, et al
    Fecal microbiota transplantation as a novel approach for the treatment of atopic dermatitis.
    J Dermatol. 2021 Sep 27. doi: 10.1111/1346-8138.16169.

  48. KIDO-NAKAHARA M, Yokote G, Yoshida M, Furue M, et al
    Atopic Dermatitis Control Tool (ADCT): A useful tool for self-evaluation in patients with atopic dermatitis.
    J Dermatol. 2021 Sep 27. doi: 10.1111/1346-8138.16176.

  49. ADACHI M, Adachi T, Yokota M, Ichimura C, et al
    A case of vancomycin-induced linear IgA bullous dermatosis with toxic epidermal necrolysis-like symptoms: Palmoplantar eruptions as a possible risk marker.
    J Dermatol. 2021 Sep 24. doi: 10.1111/1346-8138.16173.

  50. ZHANG L, Du D, Wang L, Guo L, et al
    Efficacy and safety of topical Janus kinase and phosphodiesterase inhibitor-4 inhibitors for the treatment of atopic dermatitis: A network meta-analysis.
    J Dermatol. 2021 Sep 6. doi: 10.1111/1346-8138.16126.
    PubMed     Abstract available

  51. TOTSUKA M, Watanabe T, Takamura N, Watanabe Y, et al
    A pediatric case of Stevens-Johnson syndrome with acute liver failure, resulting in liver transplantation.
    J Dermatol. 2021;48:1423-1427.
    PubMed     Abstract available

  52. KOMATSUDA E, Enzan N, Kono M
    Prochlorperazine-induced photoallergic reaction confirmed by photopatch test.
    J Dermatol. 2021;48:e464-e465.

  53. FUKUMURA E, Nakai K, Togo S, Tokimasa S, et al
    Case of Muckle-Wells syndrome with obesity.
    J Dermatol. 2021;48:e438-e439.

    August 2021
  54. CHANG PH, Huang SF, Chang PS, Yu Y, et al
    Safety considerations of systemic Janus kinase inhibitors in atopic dermatitis applications.
    J Dermatol. 2021 Aug 30. doi: 10.1111/1346-8138.16116.
    PubMed     Abstract available

  55. RAGAMIN A, de Wijs LEM, Hijnen DJ, Arends NJT, et al
    Care for children with atopic dermatitis in the Netherlands during the COVID-19 pandemic: Lessons from the first wave and implications for the future.
    J Dermatol. 2021 Aug 29. doi: 10.1111/1346-8138.16130.
    PubMed     Abstract available

  56. FUJITA K, Yagi M, Moriwaki S, Yoshida M, et al
    A phase 2b, randomized, double-blind, multicenter, vehicle-controlled study to assess the efficacy and safety of two crisaborole regimens in Japanese patients aged 2 years and older with mild-to-moderate atopic dermatitis.
    J Dermatol. 2021 Aug 26. doi: 10.1111/1346-8138.16120.
    PubMed     Abstract available

  57. KAWANO N, Inoue H, Shiratori T
    Onset of Stevens-Johnson syndrome and toxic epidermal necrolysis overlap due to tirabrutinib.
    J Dermatol. 2021 Aug 4. doi: 10.1111/1346-8138.16093.

  58. YASUNO S, Ansai O, Hayashi R, Nakamura S, et al
    Evidence for a dominant-negative effect of a missense mutation in the SERPING1 gene responsible for hereditary angioedema type I.
    J Dermatol. 2021;48:1243-1249.
    PubMed     Abstract available

    July 2021
  59. OTA M, Sasaki T, Ebihara T, Yokosawa E, et al
    Filaggrin-gene mutation has minimal effect on the disease severity in the lesions of atopic dermatitis.
    J Dermatol. 2021 Jul 29. doi: 10.1111/1346-8138.16087.
    PubMed     Abstract available

  60. TANAKA A, Morioke S, Ohya Y, Shimojo N, et al
    Comparison of the time course of atopic dermatitis from birth to 19 years old among generations of patients in Japan.
    J Dermatol. 2021 Jul 27. doi: 10.1111/1346-8138.16085.
    PubMed     Abstract available

  61. TAMAGAWA-MINEOKA R, Maruyama A, Ioka N, Masuda K, et al
    Allergic contact dermatitis due to didecyldimethylammonium chloride included in a swimsuit.
    J Dermatol. 2021 Jul 27. doi: 10.1111/1346-8138.16086.

  62. SONG D, Ran X, Chen Y, Li Z, et al
    Recurrent c.459 C>A mutation of the PERP gene results in severe Olmsted syndrome with congenital hypotrichosis, atopic dermatitis, and growth retardation.
    J Dermatol. 2021 Jul 15. doi: 10.1111/1346-8138.16060.

  63. KAMEI K, Hirose T, Yoshii N, Tanaka A, et al
    Burden of illness, medication adherence, and unmet medical needs in Japanese patients with atopic dermatitis: A retrospective analysis of a cross-sectional questionnaire survey.
    J Dermatol. 2021 Jul 6. doi: 10.1111/1346-8138.16054.
    PubMed     Abstract available

  64. HASHIMOTO H, Ito T, Ohno F, Morisawa H, et al
    Severe drug eruption induced by cyclin-dependent kinase 4 and 6 inhibitor.
    J Dermatol. 2021;48:e339-e340.

    June 2021
  65. OSADA A, Arimitsu T, Nakazaki H, Kin T, et al
    Severe drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms in a 1-month-old infant with trisomy 21.
    J Dermatol. 2021 Jun 28. doi: 10.1111/1346-8138.16042.

  66. MATSUTANI M, Imai Y, Inoue Y, Nakatani-Kusakabe M, et al
    Effectiveness and safety of tacrolimus ointment combined with dupilumab for patients with atopic dermatitis in real-world clinical practice.
    J Dermatol. 2021 Jun 22. doi: 10.1111/1346-8138.16039.
    PubMed     Abstract available

  67. UCHIDA H, Kamata M, Nagata M, Fukaya S, et al
    Baricitinib improved alopecia areata concomitant with atopic dermatitis: A case report.
    J Dermatol. 2021 Jun 20. doi: 10.1111/1346-8138.16024.

  68. HANADA M, Nakagawa M, Hamabata A, Amano H, et al
    Lipid transfer protein syndrome due to wild grape juice and various vegetables: A life-threatening food allergen.
    J Dermatol. 2021 Jun 11. doi: 10.1111/1346-8138.16010.
    PubMed     Abstract available

  69. WANG Q, Lan YP, Qi B, Yin L, et al
    Neutrophil : lymphocyte ratio is associated with disease severity and mortality in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2021 Jun 1. doi: 10.1111/1346-8138.15968.
    PubMed     Abstract available

    May 2021
  70. OLLECH A, Mashiah J, Lev A, Simon AJ, et al
    Treatment options for DOCK8 deficiency-related severe dermatitis.
    J Dermatol. 2021 May 27. doi: 10.1111/1346-8138.15955.
    PubMed     Abstract available

  71. HASHIZUME H, Fujiyama T, Kageyama R, Kaneko Y, et al
    Increased CD30(+) cells in skin lesions of drug-induced hypersensitivity syndrome: Are type-2 innate lymphoid cells present?
    J Dermatol. 2021 May 25. doi: 10.1111/1346-8138.15967.

  72. BOSMA AL, Ouwerkerk W, Gunal M, Hyseni AM, et al
    Work ability and quality of working life in atopic dermatitis patients treated with dupilumab.
    J Dermatol. 2021 May 19. doi: 10.1111/1346-8138.15939.
    PubMed     Abstract available

  73. ARAKAWA N, Inoue T, Tanji T, Amano H, et al
    Development of arthralgia during treatment with dupilumab in a patient with atopic dermatitis.
    J Dermatol. 2021 May 14. doi: 10.1111/1346-8138.15965.

  74. SHIN HT, Lee SH, Yoon HS, Heo JH, et al
    Long-term efficacy and safety of intravenous injection of clonal mesenchymal stem cells derived from bone marrow in five adults with moderate to severe atopic dermatitis.
    J Dermatol. 2021 May 14. doi: 10.1111/1346-8138.15928.
    PubMed     Abstract available

  75. KAWAI R, Suzuki S, Tanaka A, Yamazaki M, et al
    Association of lethal acquired factor XIII deficiency and type 1 diabetes mellitus with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with high levels of serum thymus and activation-regulated chemokine.
    J Dermatol. 2021 May 8. doi: 10.1111/1346-8138.15918.

  76. LUGER T, Adaskevich U, Anfilova M, Dou X, et al
    Practical algorithm to inform clinical decision-making in the topical treatment of atopic dermatitis.
    J Dermatol. 2021 May 7. doi: 10.1111/1346-8138.15921.
    PubMed     Abstract available

  77. HAYASHI E, Imanishi H, Tateishi C, Sowa-Osako J, et al
    Acute generalized exanthematous pustulosis associated with human parvovirus B19 infection in an adolescent.
    J Dermatol. 2021;48:e236-e237.

    April 2021
  78. UJIIE I, Iwata H, Yoshimoto N, Izumi K, et al
    Clinical characteristics and outcomes of bullous pemphigoid patients with versus without oral prednisolone treatment.
    J Dermatol. 2021;48:502-510.
    PubMed     Abstract available

  79. MURASE C, Takeichi T, Sugiura K, Akiyama M, et al
    Acute generalized exanthematous pustulosis triggered by acetaminophen in an IL36RN variant heterozygote.
    J Dermatol. 2021;48:e186-e187.

  80. ITAMI A, Miyagaki T, Miyano K, Takeuchi S, et al
    Intravascular large B-cell lymphoma mimicking erythema nodosum: A case report and review of published works.
    J Dermatol. 2021;48:e184-e185.

    March 2021
  81. KONDO M, Taniguchi T, Umaoka A, Iida S, et al
    Immunoglobulin G levels against Staphylococcus aureus maintained before and after treatment of severe atopic dermatitis.
    J Dermatol. 2021 Mar 28. doi: 10.1111/1346-8138.15871.

  82. FURUKAWA H, Omura R, Sugiura K, Kanazawa N, et al
    Granular C3 dermatosis-like immunological manifestation found in a case of acute generalized exanthematous pustulosis: Implication for the mechanism in C3 deposition to the epidermal basement membrane zone.
    J Dermatol. 2021 Mar 21. doi: 10.1111/1346-8138.15853.

  83. TAKEUCHI S, Inoue K, Kuretake K, Kiyomatsu-Oda M, et al
    Dupilumab shows slow, steady effectiveness for intractable prurigo in patients with atopic dermatitis.
    J Dermatol. 2021 Mar 20. doi: 10.1111/1346-8138.15843.
    PubMed     Abstract available

  84. VERGARA-DE-LA-CAMPA L, Torrado I, Recuero-Pradillo M, Torrelo A, et al
    Mastocytosis in the skin accompanied by pseudo-Kaposi's sarcoma.
    J Dermatol. 2021 Mar 8. doi: 10.1111/1346-8138.15734.
    PubMed     Abstract available

  85. WOO YR, Han Y, Lee JH, Lee YB, et al
    Real-world prevalence and burden of genital eczema in atopic dermatitis: A multicenter questionnaire-based study.
    J Dermatol. 2021 Mar 5. doi: 10.1111/1346-8138.15817.
    PubMed     Abstract available

    February 2021
  86. NOMURA T, Nakajima S, Kashiwa A, Matsuyama K, et al
    Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic syndrome followed by transient palmoplantar keratoderma-like eruption.
    J Dermatol. 2021 Feb 25. doi: 10.1111/1346-8138.15820.

  87. TANAKA A, Morioke S, Ohya Y, Shimojo N, et al
    Time course of disease severity from birth to 19 years old in patients with moderate to severe atopic dermatitis in adulthood.
    J Dermatol. 2021 Feb 23. doi: 10.1111/1346-8138.15790.

  88. JO UH, Lee JY, Lee H, Kim DY, et al
    Various skin manifestations related to inflammatory bowel disease: A nationwide cross-sectional study on the Korean population.
    J Dermatol. 2021 Feb 19. doi: 10.1111/1346-8138.15676.
    PubMed     Abstract available

  89. SAEKI H
    Preface to Journal of Dermatology special issue: Atopic dermatitis.
    J Dermatol. 2021;48:129.

  90. FUJII M, Kishibe M, Ishida-Yamamoto A
    Case of hypocomplementemic urticarial vasculitis with Sjogren's syndrome successfully treated with oral corticosteroid and colchicine.
    J Dermatol. 2021;48:e112-e113.

  91. NAGAOKA S, Hayashi S, Mori S, Kaneko Y, et al
    A case of macular rash misleading to drug eruption in secondary syphilis.
    J Dermatol. 2021;48:e104-e105.

  92. KADOWAKI S, Kimura T, Shiraki M, Mizutani Y, et al
    Case of Muckle-Wells syndrome with erythema dominantly infiltrated by lymphocytes.
    J Dermatol. 2021;48:e100-e101.

    January 2021
  93. TANAKA A, Isei M, Kikuzawa C, Hinogami H, et al
    Development of toxic epidermal necrolysis in a coronavirus disease 2019 patient with recurrence of positive SARS-CoV-2 viral RNA.
    J Dermatol. 2021 Jan 13. doi: 10.1111/1346-8138.15753.

  94. SUGIOKA K, Goto H, Sugita K, Habe K, et al
    Palisaded neutrophilic granulomatous dermatitis, interstitial granulomatous dermatitis and IgA vasculitis associated with incomplete Sjogren's syndrome.
    J Dermatol. 2021 Jan 6. doi: 10.1111/1346-8138.15738.
    PubMed     Abstract available

  95. BOSMA AL, Ouwerkerk W, Middelkamp-Hup MA
    Children with atopic eczema experiencing increased disease severity in the pollen season more often have hay fever at a young age and a dark skin type.
    J Dermatol. 2021 Jan 6. doi: 10.1111/1346-8138.15750.
    PubMed     Abstract available

  96. SCHIELEIN MC, Tizek L, Baeumer D, Hillmann E, et al
    People-centered care for psoriasis and urticaria: Are we overlooking Internet addiction while only considering patients and physician settings?
    J Dermatol. 2021 Jan 6. doi: 10.1111/1346-8138.15740.
    PubMed     Abstract available

  97. MATSUBARA D, Takahagi S, Saito R, Kamegashira A, et al
    Analysis of the long-term economic burden of omalizumab on patients with chronic spontaneous urticaria.
    J Dermatol. 2021;48:56-63.
    PubMed     Abstract available

  98. FUKAYAMA M, Domoto Y, Sato S, Asano Y, et al
    Case of aquagenic urticaria: Case report and the results of histopathological examination.
    J Dermatol. 2021;48:88-91.
    PubMed     Abstract available

  99. MAENO M, Tamagawa-Mineoka R, Arakawa Y, Masuda K, et al
    Metal patch testing in patients with oral symptoms.
    J Dermatol. 2021;48:85-87.
    PubMed     Abstract available

    December 2020
  100. MIYANO K, Tsunemi Y
    Current treatments for atopic dermatitis in Japan.
    J Dermatol. 2020 Dec 30. doi: 10.1111/1346-8138.15730.
    PubMed     Abstract available

  101. TEYE K, Koga H, Nagai A, Ohata C, et al
    Filaggrin gene (FLG) promoter polymorphisms are associated with atopic dermatitis in the Japanese population.
    J Dermatol. 2020 Dec 27. doi: 10.1111/1346-8138.15736.

  102. CHIEOSILAPATHAM P, Prinyaroj N, Jamjanya S, Kiratikanon S, et al
    Degos-like lesions as a cutaneous manifestation of cytomegalovirus infection: A rare and serious complication in a patient with drug-induced hypersensitivity syndrome.
    J Dermatol. 2020 Dec 11. doi: 10.1111/1346-8138.15717.
    PubMed     Abstract available

  103. MOTOHASHI I, Takano T, Ie K, Hashimoto Y, et al
    Development of maculopapular exanthem in a COVID-19 patient.
    J Dermatol. 2020;47:e426-e427.

    November 2020
  104. CHIANG PH, Ng CY, Kuo TT, Hui RC, et al
    Case of vitiligo universalis as a sequela of drug-induced hypersensitivity syndrome.
    J Dermatol. 2020 Nov 12. doi: 10.1111/1346-8138.15562.
    PubMed     Abstract available

  105. PUNYARATABANDHU P, Chirachanakul P
    Cutaneous eruption in COVID-19-infected patients in Thailand: An observational descriptive study.
    J Dermatol. 2020 Nov 12. doi: 10.1111/1346-8138.15625.
    PubMed     Abstract available

  106. ICHIYAMA S, Ito M, Hoashi T, Kanda N, et al
    Severe atopic dermatitis effectively treated with dupilumab changed from interleukin-5 inhibitors for concomitant severe bronchial asthma.
    J Dermatol. 2020 Nov 8. doi: 10.1111/1346-8138.15691.

    October 2020
  107. WENG YC, Juan CK, Ho HJ, Chang YL, et al
    Atopic dermatitis does not increase the risk of inflammatory bowel disease: A nationwide cohort study.
    J Dermatol. 2020 Oct 30. doi: 10.1111/1346-8138.15661.
    PubMed     Abstract available

  108. NAKAHARA T, Kido-Nakahara M, Tsuji G, Furue M, et al
    Basics and recent advances in the pathophysiology of atopic dermatitis.
    J Dermatol. 2020 Oct 29. doi: 10.1111/1346-8138.15664.
    PubMed     Abstract available

  109. AJIMA S, Sano Y, Hashizume H
    Quinolone immediate hypersensitivity due to topical ophthalmic preparations: a case report and review of literature.
    J Dermatol. 2020 Oct 28. doi: 10.1111/1346-8138.15669.
    PubMed     Abstract available

  110. SHIIYA C, Ouchi T, Funakoshi T, Amagai M, et al
    Autoimmune and inflammatory diseases occur in cases of drug-induced hypersensitivity syndrome but not in suspected cases.
    J Dermatol. 2020 Oct 18. doi: 10.1111/1346-8138.15639.

  111. ISHIURA N, Yanaba K, Nashiro K, Kudo M, et al
    Inhibitory role of interleukin-10 in the cutaneous reverse Arthus reaction.
    J Dermatol. 2020 Oct 15. doi: 10.1111/1346-8138.15641.
    PubMed     Abstract available

  112. FURUHASHI T, Oda T, Torii K, Nishida E, et al
    Dupilumab probably reduces transepidermal water loss but does not increase stratum corneum hydration in atopic dermatitis.
    J Dermatol. 2020 Oct 9. doi: 10.1111/1346-8138.15638.

  113. MUTO J, Yoshida S, Doi C, Habu M, et al
    Dupilumab treatment of atopic dermatitis leading to successful treatment of alopecia universalis: A Japanese case report.
    J Dermatol. 2020 Oct 7. doi: 10.1111/1346-8138.15631.

    September 2020
  114. BORILOVA LINHARTOVA P, Gachova D, Lipovy B
    Responsiveness to i.v. immunoglobulin therapy in patients with toxic epidermal necrolysis: A novel pharmaco-immunogenetic concept.
    J Dermatol. 2020 Sep 15. doi: 10.1111/1346-8138.15583.
    PubMed     Abstract available

    August 2020
  115. TORRES-NAVARRO I, Briz-Redon A, Botella-Casas G, Sahuquillo-Torralba A, et al
    Accuracy of SCORTEN and ABCD-10 to predict mortality and the influence of renal function in Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2020 Aug 27. doi: 10.1111/1346-8138.15490.
    PubMed     Abstract available

  116. KAWADA M, Nobeyama Y, Goto Y, Nakama K, et al
    Absence of toxic epidermal necrolysis recurrence with pembrolizumab re-challenge in a patient with a positive lymphocyte transformation test.
    J Dermatol. 2020 Aug 20. doi: 10.1111/1346-8138.15572.

    July 2020
  117. SHEN MH, Liu MT, Chung WH, Lu CW, et al
    Toxic epidermal necrolysis induced by human herpesvirus 7 treated with a tumor necrosis factor-alpha inhibitor.
    J Dermatol. 2020 Jul 19. doi: 10.1111/1346-8138.15493.
    PubMed     Abstract available

  118. KAWASAKI Y, Kamata M, Shimizu T, Nagata M, et al
    Thymus and activation-regulated chemokine (TARC) in patients with psoriasis: Increased serum TARC levels in patients with generalized pustular psoriasis.
    J Dermatol. 2020 Jul 16. doi: 10.1111/1346-8138.15511.
    PubMed     Abstract available

  119. ENDO Y, Oka A, Uehara A, Toki S, et al
    Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug.
    J Dermatol. 2020 Jul 14. doi: 10.1111/1346-8138.15510.

  120. WATANABE T, Yamaguchi Y, Watanabe Y, Takamura N, et al
    Increased level of high mobility group box 1 in the serum and skin in patients with generalized pustular psoriasis.
    J Dermatol. 2020 Jul 1. doi: 10.1111/1346-8138.15467.
    PubMed     Abstract available

    May 2020
  121. SEKIGUCHI A, Ishikawa O, Motegi SI
    Case of zinc deficiency-induced dermatomyositis-like dermatitis: Association between absence of CD1a-positive Langerhans cells and development of dermatitis.
    J Dermatol. 2020 May 15. doi: 10.1111/1346-8138.15394.

    April 2020
  122. TOMII K, Deguchi T, Katsumi T, Suzuki T, et al
    Case of toxic epidermal necrolysis successfully treated with repeated i.v. immunoglobulin.
    J Dermatol. 2020 Apr 24. doi: 10.1111/1346-8138.15356.

  123. UETSU N, Nomura Y, Matsuyama Y, Okamoto H, et al
    Characteristics and clinical significance of augmentation spectra in solar urticaria.
    J Dermatol. 2020;47:369-377.
    PubMed     Abstract available

  124. SUO H, Su H, Lu C, Yang L, et al
    Development of generalized bullous lesions after hemodialysis with polysulfone membrane dialyzer.
    J Dermatol. 2020;47:e119-e120.

    February 2020
  125. KONDO M, Suzuki K, Nakayama Y, Matsushima Y, et al
    Case of toxic epidermal necrolysis in immunocompromised patient possibly due to Streptococcus pneumoniae serotype uncovered by vaccine.
    J Dermatol. 2020 Feb 13. doi: 10.1111/1346-8138.15268.

  126. MATSUDA-HIROSE H, Sho Y, Yamate T, Nakamura Y, et al
    Acute generalized exanthematous pustulosis induced by hydroxychloroquine successfully treated with etretinate.
    J Dermatol. 2020;47:e53-e54.

  127. IHIBASHI-KUNIMI Y, Imafuku S
    Cholinergic urticaria with hypohidrosis successfully treated with omalizumab.
    J Dermatol. 2020;47:e47-e48.

    January 2020
  128. KIKUCHI S, Nobeyama Y, Saeki H, Asahina A, et al
    Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication.
    J Dermatol. 2020 Jan 7. doi: 10.1111/1346-8138.15208.
    PubMed     Abstract available

  129. NAKAMURA K, Iwata Y, Asai J, Kawakami T, et al
    Guidelines for the treatment of skin and mucosal lesions in Behcet's disease: A secondary publication.
    J Dermatol. 2020 Jan 6. doi: 10.1111/1346-8138.15207.
    PubMed     Abstract available

  130. SAWADA H, Kanehisa F, Katoh N, Asai J, et al
    Potassium iodide in successful treatment of erythema nodosum-like lesions induced by combination therapy with dabrafenib and trametinib.
    J Dermatol. 2020;47:e7-e8.

    December 2019
  131. TAKAHASHI A, Namikawa K, Nakano E, Yamazaki N, et al
    Real-world efficacy and safety data for dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation-positive advanced melanoma.
    J Dermatol. 2019 Dec 26. doi: 10.1111/1346-8138.15204.
    PubMed     Abstract available

    November 2019
  132. HASHIZUME H, Abe R, Azukizawa H, Fujiyama T, et al
    Confusion in determination of two types of cutaneous adverse reactions to drugs, maculopapular eruption and erythema multiforme, among the experts: A proposal of standardized terminology.
    J Dermatol. 2019 Nov 28. doi: 10.1111/1346-8138.15164.
    PubMed     Abstract available

    September 2019
  133. CHIANG B, Kamiya K, Sashikawa M, Maekawa T, et al
    Rare case of acquired perforating dermatosis induced by cetuximab.
    J Dermatol. 2019 Sep 20. doi: 10.1111/1346-8138.15098.

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.